YaoGeJu

Company directoryChina company filings

Suzhou Homesun Pharmaceutical Co., Ltd.

As of 17 November 2026, for the company name Suzhou Homesun Pharmaceutical Co., Ltd. as recorded, 10 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 49 records, across 27 drug names; since 21 August 2026, the records list Accepted: 1 application, No longer listed under review: 1 application, Supplement delivery: 1 application; the chemical-drug catalogue lists 22 active records with this name as holder; 31 active API registrations list this name as first registered company; 8 further acceptance records name it after the first applicant.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/17
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/17.

Drug filings

49 acceptance records as first applicant, grouped into 27 source drug names. Source data as of 2026/11/17.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Bisoprolol Fumarate and Amlodipine Besylate Tablets 2 records · Latest accepted 2026/11/10

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602763Generic2026/11/10Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
CYHS2503237Generic2025/09/03Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Salbutamol Sulfate injection 2 records · Latest accepted 2026/07/27

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2601432Supplement2026/07/27Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
CYHB2450032Supplement2024/01/10Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Azilsartan Medoxomil Potassium Tablets 2 records · Latest accepted 2026/06/04

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601306Generic2026/06/04Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
CYHS2601305Generic2026/06/04Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
硫酸特布他林口服溶液 · No verified English name 1 records · Latest accepted 2026/03/23

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2600696Generic2026/03/23Suzhou Homesun Pharmaceutical Co., Ltd.; Yang Zhou Shi San Yao Pharmaceutical Co., Ltd. romanizedCDE ↗
Eperisone Hydrochloride Tablets 1 records · Latest accepted 2026/01/21

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2600240Generic2026/01/21Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Loxoprofen Sodium Patches 2 records · Latest accepted 2025/08/15

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502994Generic2025/08/15Suzhou Homesun Pharmaceutical Co., Ltd.; Nanjing Jiu Xiao Pharma Co., Ltd. romanizedCDE ↗
CYHS2502993Generic2025/08/15Suzhou Homesun Pharmaceutical Co., Ltd.; Nanjing Jiu Xiao Pharma Co., Ltd. romanizedCDE ↗
Acetylcysteine Injection 2 records · Latest accepted 2025/07/03

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502353Generic2025/07/03Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
CYHS2401207Generic2024/04/23Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Metoclopramide Hydrochloride Injection 1 records · Latest accepted 2025/05/10

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501699Generic2025/05/10Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Amikacin Sulfate injection 2 records · Latest accepted 2025/04/03

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2550163Supplement2025/04/03Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
CYHB2550162Supplement2025/04/03Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
维生素B?注射液 · No verified English name 1 records · Latest accepted 2025/01/01

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450650Supplement2025/01/01Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Famotidine Injection 1 records · Latest accepted 2024/09/03

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402887Generic2024/09/03Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Tenofovir Disoproxil Fumarate Tablets 1 records · Latest accepted 2024/02/18

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2400257Supplement2024/02/18Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
螺内酯片 · No verified English name 2 records · Latest accepted 2023/12/12

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2350926Supplement2023/12/12Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
CYHB2350925Supplement2023/12/12Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
盐酸左沙丁胺醇雾化吸入溶液 · No verified English name 3 records · Latest accepted 2023/12/05

Generic · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2303339Generic2023/12/05Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
CYHS2303338Generic2023/12/05Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
CYHS2303337Generic2023/12/05Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
硫酸特布他林雾化吸入用溶液 · No verified English name 1 records · Latest accepted 2023/08/15

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2301793Supplement2023/08/15Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Salbutamol Sulfate Inhalation Solution 1 records · Latest accepted 2023/07/12

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2301562Supplement2023/07/12Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Compound Ipratropium Bromide Solution For Inhalation 1 records · Latest accepted 2023/05/25

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2301415Generic2023/05/25Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Tadalafil Tablets 5 records · Latest accepted 2023/05/05

Generic · 5

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2301209Generic2023/05/05Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
CYHS2300967Generic2023/04/05Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
CYHS2300966Generic2023/04/05Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
CYHS2101362Generic2021/07/02Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
CYHS2101361Generic2021/07/02Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Ipratropium Bromide Inhalation Solution 2 records · Latest accepted 2023/04/29

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2301201Generic2023/04/29Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
CYHS2301200Generic2023/04/29Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Acetylcysteine Solution For Inhalation 1 records · Latest accepted 2023/03/21

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2300845Generic2023/03/21Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Amiodarone Hydrochloride Injection 1 records · Latest accepted 2023/03/17

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2300813Generic2023/03/17Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Levofloxacin Tablets 2 records · Latest accepted 2023/02/03

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2300316Generic2023/02/03Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
CYHS2300315Generic2023/02/03Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Levofloxacin Eye Drops 4 records · Latest accepted 2023/01/11

Generic · 4

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2300101Generic2023/01/11Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
CYHS2300100Generic2023/01/11Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
CYHS2300099Generic2023/01/11Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
CYHS2300098Generic2023/01/11Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Sodium Hyaluronate Eye Drops 4 records · Latest accepted 2023/01/11

Generic · 4

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2300086Generic2023/01/11Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
CYHS2300085Generic2023/01/11Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
CYHS2300084Generic2023/01/11Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
CYHS2300083Generic2023/01/11Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
盐酸雷尼替丁胶囊 · No verified English name 2 records · Latest accepted 2021/08/03

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150775Supplement2021/08/03Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
CYHB2101399Supplement2021/06/18Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Tenofovir alafenamide Fumarate Tablets 1 records · Latest accepted 2021/04/23

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2101085Generic2021/04/23Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Ambroxol Hydrochloride Solution For Inhalation 1 records · Latest accepted 2021/01/06

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2100007Generic2021/01/06Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗

Changes in the last 90 days

3 events from 2026/08/21 to 2026/11/18. CDE data as of 2026/11/17; NMPA data as of 2026/11/17.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Accepted: 1 applicationNo longer listed under review: 1 applicationSupplement delivery: 1 application

  1. 2026/11/10Accepted

    Bisoprolol Fumarate and Amlodipine Besylate Tablets

    CYHS2602763

    Fact date: 2026/11/10 · Date added to this site: 2026/11/11

    View source ↗
  2. 2026/10/23No longer listed under review

    Salbutamol Sulfate injection

    CYHB2601432

    Fact date: 2026/10/23 · Date added to this site: 2026/10/23

    Accepted: 2026/07/27

    no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/10/23 (approval no.: —; approval date: 2026/10/21); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 16

    NMPA · Table row 16 ↗ View source ↗
  3. 2026/10/21Supplement delivery

    Salbutamol Sulfate injection

    CYHB2601432

    Fact date: 2026/10/21 · Publication date: 2026/10/23 · Date added to this site: 2026/11/03

    Supplemental application; excluded from new marketing approvals.

    View source · Table row 16 ↗

Under review

10 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/17.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Bisoprolol Fumarate and Amlodipine Besylate Tablets CYHS2602763Generic2026/11/10Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Azilsartan Medoxomil Potassium Tablets CYHS2601306Generic2026/06/04Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Azilsartan Medoxomil Potassium Tablets CYHS2601305Generic2026/06/04Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
硫酸特布他林口服溶液 · No verified English name CYHS2600696Generic2026/03/23Suzhou Homesun Pharmaceutical Co., Ltd.; Yang Zhou Shi San Yao Pharmaceutical Co., Ltd. romanizedCDE ↗
Eperisone Hydrochloride Tablets CYHS2600240Generic2026/01/21Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Loxoprofen Sodium Patches CYHS2502994Generic2025/08/15Suzhou Homesun Pharmaceutical Co., Ltd.; Nanjing Jiu Xiao Pharma Co., Ltd. romanizedCDE ↗
Loxoprofen Sodium Patches CYHS2502993Generic2025/08/15Suzhou Homesun Pharmaceutical Co., Ltd.; Nanjing Jiu Xiao Pharma Co., Ltd. romanizedCDE ↗
Acetylcysteine Injection CYHS2502353Generic2025/07/03Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Metoclopramide Hydrochloride Injection CYHS2501699Generic2025/05/10Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
盐酸雷尼替丁胶囊 · No verified English name CYHB2150775Supplement2021/08/03Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗

Catalogue holder records

22 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/17. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Amikacin Sulfate injectionSuzhou Homesun Pharmaceutical Co., Ltd.Suzhou Homesun Pharmaceutical Co., Ltd.国药准字H320200242026/06/02Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Amikacin Sulfate injectionSuzhou Homesun Pharmaceutical Co., Ltd.Suzhou Homesun Pharmaceutical Co., Ltd.国药准字H320225182026/06/02Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Famotidine InjectionSuzhou Homesun Pharmaceutical Co., Ltd.Suzhou Homesun Pharmaceutical Co., Ltd.国药准字H202644802026/05/19Generic approved under the new chemical-drug registration classificationCDE ↗
维生素B6注射液 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Suzhou Homesun Pharmaceutical Co., Ltd.国药准字H202690482026/03/04Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Salbutamol Sulfate injectionSuzhou Homesun Pharmaceutical Co., Ltd.Suzhou Homesun Pharmaceutical Co., Ltd.国药准字H202580662025/04/21Drug that passed quality-and-efficacy consistency evaluationCDE ↗
螺内酯片 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Suzhou Homesun Pharmaceutical Co., Ltd.国药准字H202472202024/09/20Drug that passed quality-and-efficacy consistency evaluationCDE ↗
螺内酯片 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Suzhou Homesun Pharmaceutical Co., Ltd.国药准字H202472192024/09/20Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Amiodarone Hydrochloride InjectionSuzhou Homesun Pharmaceutical Co., Ltd.Suzhou Homesun Pharmaceutical Co., Ltd.国药准字H202445262024/07/30Not stated by sourceCDE ↗
Tadalafil TabletsSuzhou Homesun Pharmaceutical Co., Ltd.Suzhou Homesun Pharmaceutical Co., Ltd.国药准字H202443512024/06/28Generic approved under the new chemical-drug registration classificationCDE ↗
Levofloxacin TabletsSuzhou Homesun Pharmaceutical Co., Ltd.Suzhou Homesun Pharmaceutical Co., Ltd.国药准字H202441722024/06/28Generic approved under the new chemical-drug registration classificationCDE ↗
Tadalafil TabletsSuzhou Homesun Pharmaceutical Co., Ltd.Suzhou Homesun Pharmaceutical Co., Ltd.国药准字H202443522024/06/28Generic approved under the new chemical-drug registration classificationCDE ↗
Tadalafil TabletsSuzhou Homesun Pharmaceutical Co., Ltd.Suzhou Homesun Pharmaceutical Co., Ltd.国药准字H202443572024/06/28Generic approved under the new chemical-drug registration classificationCDE ↗
Tenofovir alafenamide Fumarate TabletsSuzhou Homesun Pharmaceutical Co., Ltd.Suzhou Homesun Pharmaceutical Co., Ltd.国药准字H202335592023/05/19Generic approved under the new chemical-drug registration classificationCDE ↗
Tadalafil TabletsSuzhou Homesun Pharmaceutical Co., Ltd.Suzhou Homesun Pharmaceutical Co., Ltd.国药准字H202230662022/01/30Generic approved under the new chemical-drug registration classificationCDE ↗
PYRAZINAMIDE TabletsSuzhou Homesun Pharmaceutical Co., Ltd.Suzhou Homesun Pharmaceutical Co., Ltd.国药准字H320244902022/01/18Drug that passed quality-and-efficacy consistency evaluationCDE ↗
PYRAZINAMIDE TabletsSuzhou Homesun Pharmaceutical Co., Ltd.Suzhou Homesun Pharmaceutical Co., Ltd.国药准字H320244912022/01/18Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Metronidazole TabletsSuzhou Homesun Pharmaceutical Co., Ltd.Suzhou Homesun Pharmaceutical Co., Ltd.国药准字H320200522021/11/23Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Phenytoin Sodium TabletsSuzhou Homesun Pharmaceutical Co., Ltd.Suzhou Homesun Pharmaceutical Co., Ltd.国药准字H320225282021/08/13Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Phenytoin Sodium TabletsSuzhou Homesun Pharmaceutical Co., Ltd.Suzhou Homesun Pharmaceutical Co., Ltd.国药准字H320200462021/08/13Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Ketotifen Fumarate TabletsSuzhou Homesun Pharmaceutical Co., Ltd.Suzhou Homesun Pharmaceutical Co., Ltd.国药准字H320259962021/04/20Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Tenofovir Disoproxil Fumarate TabletsSuzhou Homesun Pharmaceutical Co., Ltd.Suzhou Homesun Pharmaceutical Co., Ltd.国药准字H202132612021/04/07Generic approved under the new chemical-drug registration classificationCDE ↗
Salbutamol TabletsSuzhou Homesun Pharmaceutical Co., Ltd.Suzhou Homesun Pharmaceutical Co., Ltd.国药准字H320241292021/01/05Drug that passed quality-and-efficacy consistency evaluationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

31 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/17.

NameCompany / applicantRegistration numberStatusSource update dateView source
盐酸乙哌立松 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20250000745I2025/07/23CDE ↗
二巯丁二酸 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20250000093I2025/03/03CDE ↗
盐酸甲氧氯普胺 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20240000980I2024/12/24CDE ↗
盐酸左沙丁胺醇 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20230001117A2025/07/29CDE ↗
枸橼酸托法替布 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20210000863A2023/07/24CDE ↗
舒更葡糖钠 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20200000565A2025/03/21CDE ↗
富马酸丙酚替诺福韦 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20200000146A2023/05/26CDE ↗
他达拉非 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20200000272A2026/09/29CDE ↗
非布司他 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20200000273A2026/07/17CDE ↗
盐酸雷尼替丁 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20190008028A2025/08/14CDE ↗
富马酸替诺福韦二吡呋酯 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20190006639A2026/08/06CDE ↗
双氯芬酸钾 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20190004729A2025/06/28CDE ↗
利巴韦林 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20190004728A2025/08/30CDE ↗
盐酸左氧氟沙星 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20190004721A2025/08/14CDE ↗
甲硝唑 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20190003215A2025/06/06CDE ↗
苯妥英钠 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20190003214A2025/06/13CDE ↗
林旦 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20190003213A—CDE ↗
盐酸哌仑西平 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20190003212A2025/06/28CDE ↗
盐酸噻氯匹定 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20190003211A2025/06/07CDE ↗
硫酸沙丁胺醇 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20190003210A2025/06/06CDE ↗
盐酸多塞平 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20190003209A2025/06/07CDE ↗
盐酸克仑特罗 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20190003208A2025/06/28CDE ↗
硫糖铝 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20190003207A2025/06/06CDE ↗
牛磺酸 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20190003206A2025/05/30CDE ↗
卡苯达唑 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20190003205A—CDE ↗
硝苯地平 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20190003204A2025/06/07CDE ↗
磺胺嘧啶银 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20190003203A2025/06/06CDE ↗
富马酸酮替芬 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20190003202A2025/06/07CDE ↗
沙丁胺醇 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20190003201A2025/05/31CDE ↗
盐酸酚苄明 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20190003200A2025/06/28CDE ↗
硫酸特布他林 · No verified English nameSuzhou Homesun Pharmaceutical Co., Ltd.Y20170002314A2025/09/16CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

8 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/17.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Tadalafil Tablets CYHB2401974Supplement2024/11/22Hainan Hong Xiang Qi Rong Pharmaceuticals Technology Co., Ltd. romanized; Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Tadalafil Tablets CYHB2401973Supplement2024/11/22Hainan Hong Xiang Qi Rong Pharmaceuticals Technology Co., Ltd. romanized; Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Tadalafil Tablets CYHB2401972Supplement2024/11/22Hainan Hong Xiang Qi Rong Pharmaceuticals Technology Co., Ltd. romanized; Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Citicoline Sodium Injection CYHB2250668Supplement2022/10/26Suzhou Te Rui Pharma Co., Ltd. romanized; Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Tadalafil Tablets CYHB2201841Supplement2022/10/10Hainan Hong Xiang Qi Rong Pharmaceuticals Technology Co., Ltd. romanized; Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Citicoline Sodium Injection CYHB2201466Supplement2022/08/19Suzhou Te Rui Pharma Co., Ltd. romanized; Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Tofacitinib Citrate Tablets CYHS2200052Generic2022/01/12Jiangsu Kang Bei De Pharma Co., Ltd. romanized; Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗
Tofacitinib Citrate Tablets CYHS2102079Generic2021/11/25Jiangsu Kang Bei De Pharma Co., Ltd. romanized; Suzhou Homesun Pharmaceutical Co., Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/17
Chemical-drug catalogue
Last successful update: 2026/11/17
API registrations
Last successful update: 2026/11/17
NMPA drug delivery notices
Last successful update: 2026/11/17

Loaded notices dated 2026-11-03 to 2026-11-17; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.